Cyclic interferon gamma treatment of patients with metastatic renal carcinoma.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  British Journal of Urology

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1464-410X.1989.TB06000.XPMID 2508986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants.

  1987cited by this paper
• Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

  1986cited by this paper
• Interferon therapy for the treatment of renal cancer

  1986cited by this paper
• Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.

  1985cited by this paper
• A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.

  1985cited by this paper
• Immunological findings in patients with superficial bladder cancer during human alpha-2-interferon treatment.

  1985cited by this paper
• Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.

  1985cited by this paper
• Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant γ-lnterferon in Cancer Patients

  1985cited by this paper
• Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system.

  1984cited by this paper

• RNA-Based Therapies in Kidney Diseases

  2025cites this paper
• Title In Vivo and in Vitro Activation of Lymphocytes by IFN-α and IFN-γ inPatients with Renal Cell Carcinoma

  2018cites this paper
• A United States Patent ( 19 ) 11 Patent Number : 6 , 018 , 678 Mitragotri

  2017cites this paper
• A United States Patent ( 19 ) 11 Patent Number : 5 , 947 , 921

  2017cites this paper
• Systemic Therapy for Metastatic Renal Cell Carcinoma: Cytokines

  2008cites this paper
• Immuntherapie beim Nierenzellkarzinom

  2007cites this paper
• Role of Interferon in Metastatic Renal Cell Carcinoma

  2000cites this paper
• Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial. Austrian Renal Cell Carcinoma Study Group.

  2000cites this paper
• Cytokine therapy in renal cell cancer.

  2000cites this paper
• The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.

  1998cites this paper
• Immunotherapy of metastatic renal cell cancer.

  1996cites this paper
• Ultrasound-mediated transdermal protein delivery

  1995cites this paper
• [Treatment of advanced renal cell carcinoma with a combination of interferon alpha and gamma].

  1995cites this paper
• Activation of cytokine production and adhesion molecule expression on THP‐1 myelomonocytic cells by macrophage colony‐stimulating factor in combination with interferon‐γ

  1995cites this paper
• expression on THE-i myelomonocytic cells by macrophage colony-stimulating factor in combination with interleron-y

  1995cites this paper
• Tumours in Urology

  1994cites this paper
• The management of renal cell carcinoma.

  1994cites this paper
• Immunotherapy in the Management of Metastatic Renal Cell Carcinoma

  1994cites this paper
• In Vivo and in Vitro Activation of Lymphocytes by IFN-α and IFN-γ in Patients with Renal Cell Carcinoma

  1994cites this paper
• Immuntherapie des metastasierten Nierenzellkarzinoms mit rekombinantem Interferon-γ

  1993cites this paper
• [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].

  1993cites this paper
• Immunotherapy for metastatic renal cell carcinoma.

  1993cites this paper
• [Immunotherapy of metastatic renal cell cancer].

  1993cites this paper
• Interleukin‐2 in Association with Increasing Doses of Interferon‐Gamma in Patients with Advanced Cancer

  1992cites this paper
• Behandlung des metastasierten Nierenzellkarzinoms mit rekombinantem Gamma-Interferon

  1991cites this paper